GE HealthCare Technologies Inc. Reports Strong Q1 Performance

In an impressive start to the fiscal year, GE HealthCare Technologies Inc. announced a 3% year-on-year revenue increase, reaching $4.8 billion in the first quarter of 2025. This performance not only surpassed expectations but also marked a significant milestone for the company.

Financial Highlights

The company's net income saw a remarkable 50.8% jump compared to the same quarter in 2024, totaling $564 million. Additionally, diluted earnings per share (EPS) experienced a 51.85% annual increase, landing at $1.23. In a move to return value to shareholders, GE HealthCare revealed a $1 billion share repurchase program.

Leadership Insights

"Our first-quarter results demonstrate strong execution and set a positive tone for the year. With robust revenue, orders, and profit growth, particularly in the U.S., we're well-positioned to advance our precision care and growth acceleration strategies," stated CEO Peter Arduini. He also highlighted the strategic acquisition of Nihon Medi-Physics, expected to enhance global access to next-generation radiopharmaceuticals.

Market Response

Following the announcement, GE HealthCare's stock price rose by 2.81% in premarket trading, reaching $70 per share at 6:29 am ET, reflecting investor confidence in the company's growth trajectory.